Livzon Pharma (01513.HK) announced that the board of directors meeting will be held on Thursday, August 22, 2024, to review and approve the unaudited semi-annual performance of the company and its subsidiaries ending on June 30, 2024, and to handle other matters.
丽珠医药(01513.HK)8月22日举行董事会会议审议及批准半年度业绩
Livzon Pharma (01513.HK) held a board of directors meeting on August 22 to review and approve the semi-annual results.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.